Module II -  New FDA Actions

Monday August 17, 1998 - Question 3

Which of the following statements regarding thalidomide (Thalomid) is correct?

A) Thalidomide may be prescribed by any practitioner with a valid DEA number.
 
B) Pharmacists may dispense thalidomide to female patients without special consideration.
 
C) Male patients do not need to take special precautions regarding contraception.
 
D) Thalidomide was recently FDA approved for treatment of erythema nodosum leprosum (ENL).
 
E) Birth defects are the only serious side effects associated with thalidomide.

.
 

Discussion